Could a higher dose of buprenorphine keep more people in opioid treatment?
NCT ID NCT06316830
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 26 times
Summary
This study compares two daily doses of buprenorphine (16 mg vs. 24 mg) to see if a higher dose helps people with opioid use disorder stay in treatment longer and reduce cravings. Researchers will enroll 250 adults who have used fentanyl and are starting or continuing buprenorphine therapy. The goal is to improve treatment retention and lower the risk of overdose.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Brown University
RECRUITINGProvidence, Rhode Island, 02912, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.